Abbott Earns CE Mark for Blood Test to Predict Cardiac Events

Abbott’s Troponin-I blood test has received CE Mark approval for predicting a patient’s chance of heart attack or other cardiac event.

The blood test can predict, potentially within months to years in advance, if patients who otherwise seem healthy may experience heart attacks or cardiac events.

Because the test can detect levels of troponin — even if they are very low — it can be used to determine cardiac risks in patients who exhibit no symptoms.